These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 24709589)

  • 21. Efficacy of commercial genotype 1 porcine reproductive and respiratory syndrome virus (PRRSV) vaccine against field isolate of genotype 2 PRRSV.
    Ko SS; Seo SW; Sunwoo SY; Yoo SJ; Kim MH; Lyoo YS
    Vet Immunol Immunopathol; 2016 Apr; 172():43-9. PubMed ID: 27032502
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunity raised by recent European subtype 1 PRRSV strains allows better replication of East European subtype 3 PRRSV strain Lena than that raised by an older strain.
    Trus I; Frydas IS; Reddy VR; Bonckaert C; Li Y; Kvisgaard LK; Larsen LE; Nauwynck HJ
    Vet Res; 2016 Jan; 47():15. PubMed ID: 26742636
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of modified-live porcine reproductive and respiratory syndrome virus (PRRSv) vaccine on the shedding of wild-type virus from an infected population of growing pigs.
    Linhares DC; Cano JP; Wetzell T; Nerem J; Torremorell M; Dee SA
    Vaccine; 2012 Jan; 30(2):407-13. PubMed ID: 22063389
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Similarity of European porcine reproductive and respiratory syndrome virus strains to vaccine strain is not necessarily predictive of the degree of protective immunity conferred.
    Prieto C; Alvarez E; Martínez-Lobo FJ; Simarro I; Castro JM
    Vet J; 2008 Mar; 175(3):356-63. PubMed ID: 17560818
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reproductive performance of gilts following vaccination and subsequent heterologous challenge with European strains of porcine reproductive and respiratory syndrome virus.
    Scortti M; Prieto C; Simarro I; Castro JM
    Theriogenology; 2006 Nov; 66(8):1884-93. PubMed ID: 16806451
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of the safety and efficacy of an attenuated live vaccine based on highly pathogenic porcine reproductive and respiratory syndrome virus.
    Yu X; Zhou Z; Cao Z; Wu J; Zhang Z; Xu B; Wang C; Hu D; Deng X; Han W; Gu X; Zhang S; Li X; Wang B; Zhai X; Tian K
    Clin Vaccine Immunol; 2015 May; 22(5):493-502. PubMed ID: 25739919
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cross-protection of a modified-live porcine reproductive and respiratory syndrome virus (PRRSV)-2 vaccine against a heterologous PRRSV-1 challenge in late-term pregnancy gilts.
    Jeong J; Park C; Oh T; Park KH; Yang S; Kang I; Park SJ; Chae C
    Vet Microbiol; 2018 Sep; 223():119-125. PubMed ID: 30173737
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transmission of Porcine reproductive and respiratory syndrome virus 1 to and from vaccinated pigs in a one-to-one model.
    Pileri E; Gibert E; Martín-Valls GE; Nofrarias M; López-Soria S; Martín M; Díaz I; Darwich L; Mateu E
    Vet Microbiol; 2017 Mar; 201():18-25. PubMed ID: 28284607
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Co-administration of saponin quil A and PRRSV-1 modified-live virus vaccine up-regulates gene expression of type I interferon-regulated gene, type I and II interferon, and inflammatory cytokines and reduces viremia in response to PRRSV-2 challenge.
    Charerntantanakul W; Pongjaroenkit S
    Vet Immunol Immunopathol; 2018 Nov; 205():24-34. PubMed ID: 30458999
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reproductive, productivity, and mortality outcomes in late-gestation gilts and their litters following simulation of inadvertent exposure to a modified-live vaccine strain of porcine reproductive and respiratory syndrome (PRRS) virus.
    Schelkopf A; Nerem J; Cowles B; Amodie D; Swalla R; Dee S
    Vaccine; 2014 Aug; 32(36):4639-43. PubMed ID: 24975816
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of a killed porcine reproductive and respiratory syndrome virus (PRRSV) vaccine treatment on virus shedding in previously PRRSV infected pigs.
    Nilubol D; Platt KB; Halbur PG; Torremorell M; Harris DL
    Vet Microbiol; 2004 Aug; 102(1-2):11-8. PubMed ID: 15288922
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vaccination against porcine reproductive and respiratory syndrome virus (PRRSV) reduces the magnitude and duration of viremia following challenge with a virulent heterologous field strain.
    Calvert JG; Keith ML; Pearce DS; Lenz MC; King VL; Diamondidis YA; Ankenbauer RG; Martinon NC
    Vet Microbiol; 2017 Jun; 205():80-83. PubMed ID: 28622868
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of challenge with a virulent genotype II strain of porcine reproductive and respiratory syndrome virus on piglets vaccinated with an attenuated genotype I strain vaccine.
    Roca M; Gimeno M; Bruguera S; Segalés J; Díaz I; Galindo-Cardiel IJ; Martínez E; Darwich L; Fang Y; Maldonado J; March R; Mateu E
    Vet J; 2012 Jul; 193(1):92-6. PubMed ID: 22264642
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of a modified-live virus vaccine against porcine reproductive and respiratory syndrome in boars.
    Christopher-Hennings J; Nelson EA; Nelson JK; Benfield DA
    Am J Vet Res; 1997 Jan; 58(1):40-5. PubMed ID: 8989494
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of a modified-live virus vaccine in pigs experimentally infected with a highly pathogenic porcine reproductive and respiratory syndrome virus type 1 (HP-PRRSV-1).
    Canelli E; Catella A; Borghetti P; Ferrari L; Ogno G; De Angelis E; Bonilauri P; Guazzetti S; Nardini R; Martelli P
    Vet Microbiol; 2018 Nov; 226():89-96. PubMed ID: 30389048
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of a type 2 PRRSV modified live vaccine (PrimePac™ PRRS) against a Thai HP-PRRSV challenge.
    Sirisereewan C; Woonwong Y; Arunorat J; Kedkovid R; Nedumpun T; Kesdangsakonwut S; Suradhat S; Thanawongnuwech R; Teankum K
    Trop Anim Health Prod; 2018 Oct; 50(7):1509-1518. PubMed ID: 29696456
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Porcine circovirus type 2 infection decreases the efficacy of a modified live porcine reproductive and respiratory syndrome virus vaccine.
    Opriessnig T; McKeown NE; Harmon KL; Meng XJ; Halbur PG
    Clin Vaccine Immunol; 2006 Aug; 13(8):923-9. PubMed ID: 16893993
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Respiratory tract protection upon challenge of pigs vaccinated with attenuated porcine reproductive and respiratory syndrome virus vaccines.
    Labarque G; Van Gucht S; Van Reeth K; Nauwynck H; Pensaert M
    Vet Microbiol; 2003 Sep; 95(3):187-97. PubMed ID: 12935746
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protective immunity induced by a recombinant pseudorabies virus expressing the GP5 of porcine reproductive and respiratory syndrome virus in piglets.
    Qiu HJ; Tian ZJ; Tong GZ; Zhou YJ; Ni JQ; Luo YZ; Cai XH
    Vet Immunol Immunopathol; 2005 Jul; 106(3-4):309-19. PubMed ID: 15963827
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Natural infection with torque teno sus virus 1 (TTSuV1) suppresses the immune response to porcine reproductive and respiratory syndrome virus (PRRSV) vaccination.
    Zhang Z; Wang Y; Fan H; Lu C
    Arch Virol; 2012 May; 157(5):927-33. PubMed ID: 22327391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.